EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety

Yeyi Zhu iD, Monique M Hedderson

Human Reproduction Open · 12.03.2026 · 2026 (2)

DOI: 10.1093/hropen/hoag016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction Open, online erschienen am 18.03.2026. Verfasst von Yeyi Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA.
  • Center for Upstream Prevention of Adiposity and Diabetes Mellitus (UPSTREAM), Pleasanton, CA, USA.

ORCID-Profile: Yeyi Zhu

Zitieren

APA

Zhu, Y., & Hedderson, M. M. (2026). When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety. Human Reproduction Open, 2026(2). https://doi.org/10.1093/hropen/hoag016

Vancouver

Zhu Y, Hedderson MM. When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety. Human Reproduction Open. 2026;2026(2). doi:10.1093/hropen/hoag016

BibTeX
@article{Zhu2026,
  author = {Zhu, Yeyi and Hedderson, Monique M},
  title = {When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety},
  journal = {Human Reproduction Open},
  year = {2026},
  volume = {2026},
  number = {2},
  doi = {10.1093/hropen/hoag016}
}
Kostenlos starten →